Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 19 tags : Therapy save search
Galera Announces Results of Phase 3 ROMAN Trial of Avasopasem for Radiotherapy-Induced Severe Oral Mucositis
Published: 2021-10-19 (Crawled : 14:00) - biospace.com/
GRTX | $0.1833 -1.45% -1.47% 800K
|
Health Technology
|
| O: -72.03%
H: 22.71%
C: 8.7%
therapy results phase 3 iot trial oral mucositis avasopasem roman trial
MeiraGTx Announces the Presentation of Two Novel Inherited Retinal Disease (IRD) Programs and Riboswitch Gene Regulation Platform at the European Society of Gene and Cell Therapy (ESGCT) 2021 Annual Congress
Published: 2021-10-19 (Crawled : 14:00) - globenewswire.com
MGTX | $5.09 1.6% 1.57% 190K
|
Health Technology
|
| O: -0.11%
H: 10.03%
C: 2.75%
presentation disease europe therapy retina
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
Published: 2021-10-19 (Crawled : 13:00) - globenewswire.com
STIM | $3.8 -0.78% -0.79% 49K
|
Health Technology
|
| O: -1.19%
H: 5.02%
C: 5.02%
therapy health
AVROBIO Reports New Interim Safety Data Across Investigational Gene Therapies for Fabry and Gaucher Disease Type 1
Published: 2021-10-19 (Crawled : 12:00) - biospace.com/
AVRO | $1.205 -2.82% -2.9% 39K
|
Health Technology
|
| O: 0.54%
H: 3.66%
C: 1.25%
disease gene therapies gene therapy therapy
Rocket Pharmaceuticals Announces Presentations Highlighting Lentiviral Gene Therapies at the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)
Published: 2021-10-19 (Crawled : 11:00) - biospace.com/
RCKT M | $22.82 -2.81% -2.89% 960K
|
Health Technology
|
| O: 1.38%
H: 1.89%
C: 0.61%
presentation europe gene therapies therapy gene therapy
Myovant Sciences and Pfizer Present Data on Relugolix Combination Therapy from Studies in Uterine Fibroids and Endometriosis at the American Society for Reproductive Medicine Congress
Published: 2021-10-19 (Crawled : 11:00) - globenewswire.com
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.68%
H: 1.44%
C: 1.18%
MYOV | $26.98 -0.04% 0.0% 0
|
Health Technology
|
| O: 0.3%
H: 3.0%
C: -0.15%
uterine fibroids therapy
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.